Cellectar Biosciences (CLRB) Earnings Date, Estimates & Call Transcripts $4.88 -0.05 (-1.01%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$4.89 +0.01 (+0.12%) As of 07/11/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cellectar Biosciences Earnings Summary Cellectar Biosciences released Q1 2025 earnings on May 13, 2025, reporting an EPS of -$3.90, which beat analysts' consensus estimates of -$5.10 by $1.20. With a trailing EPS of -$21.92, Cellectar Biosciences' earnings are expected to grow next year, from ($1.59) to ($0.72) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 13) -$5.10 Actual EPS (May. 13) -$3.90 Beat By $1.20 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)CLRB Upcoming EarningsCellectar Biosciences' next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules. Powered by Get Cellectar Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cellectar Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCLRB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Cellectar Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$5.40-$5.40-$5.40Q2 20251-$3.60-$3.60-$3.60Q3 20251-$3.00-$3.00-$3.00Q4 20251-$3.00-$3.00-$3.00 Cellectar Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/13/2025Q1 2025-$5.10-$3.90+$1.20-$0.14--10/29/2024Q3 2024--$15.30--$0.84--5/14/2024Q1 2024-$15.00-$12.00+$3.00-$0.06--3/27/2024Q4 2023-$17.70-$19.80 -$2.10-$0.92--11/13/2023Q3 2023-$13.20-$24.60 -$11.40-$0.43--8/14/2023Q2 2023-$20.70-$21.90 -$1.20-$0.73-- Cellectar Biosciences Earnings - Frequently Asked Questions When is Cellectar Biosciences' earnings date? Cellectar Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on CLRB's earnings history. Did Cellectar Biosciences beat their earnings estimates last quarter? In the previous quarter, Cellectar Biosciences (NASDAQ:CLRB) reported ($3.90) earnings per share (EPS) to beat the analysts' consensus estimate of ($5.10) by $1.20. Learn more on analysts' earnings estimate vs. CLRB's actual earnings. How can I listen to Cellectar Biosciences' earnings conference call? The conference call for Cellectar Biosciences' latest earnings report can be listened to online. Listen to Conference Call How can I read Cellectar Biosciences' conference call transcript? The conference call transcript for Cellectar Biosciences' latest earnings report can be read online. Read Transcript How much profit does Cellectar Biosciences generate each year? Cellectar Biosciences (NASDAQ:CLRB) has a recorded net income of -$44.58 million. CLRB has generated -$21.92 earnings per share over the last four quarters. What is Cellectar Biosciences' EPS forecast for next year? Cellectar Biosciences' earnings are expected to grow from ($1.59) per share to ($0.72) per share in the next year. More Earnings Resources from MarketBeat Related Companies LAVA Therapeutics Earnings Date Telomir Pharmaceuticals Earnings Date Rein Therapeutics Earnings Date KALA BIO Earnings Date Lantern Pharma Earnings Date Kezar Life Sciences Earnings Date OnKure Therapeutics Earnings Date Estrella Immunopharma Earnings Date Synergy CHC Earnings Date Rani Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s Next This page (NASDAQ:CLRB) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectar Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectar Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLRB Stock Alerts